BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 23618840)

  • 21. Evaluation of
    Parvez MM; Shin HJ; Jung JA; Shin JG
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223391
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
    El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
    Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of drug transporters involved in the urinary secretion of [
    Kobayashi M; Mizutani A; Okamoto T; Muranaka Y; Nishi K; Nishii R; Shikano N; Nakanishi T; Tamai I; Kleinerman ES; Kawai K
    Nucl Med Biol; 2021; 94-95():92-97. PubMed ID: 33609918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin and probenecid inhibit organic anion transporter 3-mediated renal uptake of cilostazol and probenecid induces metabolism of cilostazol in the rat.
    Wang C; Wang C; Liu Q; Meng Q; Cang J; Sun H; Peng J; Ma X; Huo X; Liu K
    Drug Metab Dispos; 2014 Jun; 42(6):996-1007. PubMed ID: 24692216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of uremic toxin transport by organic anion transporters in the kidney.
    Deguchi T; Kusuhara H; Takadate A; Endou H; Otagiri M; Sugiyama Y
    Kidney Int; 2004 Jan; 65(1):162-74. PubMed ID: 14675047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient.
    Sweet DH; Chan LM; Walden R; Yang XP; Miller DS; Pritchard JB
    Am J Physiol Renal Physiol; 2003 Apr; 284(4):F763-9. PubMed ID: 12488248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effect of COX1 and COX2 inhibitors on renal outcomes following ischemic acute kidney injury.
    Bischoff A; Bucher M; Gekle M; Sauvant C
    Am J Nephrol; 2014; 40(1):1-11. PubMed ID: 24943263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal expression and function of oat1 and oat3 in rats with vascular calcification.
    Bulacio R; Hazelhoff MH; Torres AM
    Pharmacology; 2012; 90(1-2):66-77. PubMed ID: 22759781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of 1α,25-dihydroxyvitamin D3 , the natural vitamin D receptor ligand, on the pharmacokinetics of cefdinir and cefadroxil, organic anion transporter substrates, in rat.
    Kim YC; Kim IB; Noh CK; Quach HP; Yoon IS; Chow ECY; Kim M; Jin HE; Cho KH; Chung SJ; Pang KS; Maeng HJ
    J Pharm Sci; 2014 Nov; 103(11):3793-3805. PubMed ID: 25266751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 99mTc-mercaptoacetyltriglycine camera-based measurement of renal clearance: should the result be normalized for body surface area?
    Klingensmith WC
    J Nucl Med Technol; 2013 Dec; 41(4):279-82. PubMed ID: 24167023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of rat renal cortical organic anion transporter (OAT1 and OAT3) expression in response to ischemia/reperfusion injury.
    Zhang R; Yang X; Li J; Wu J; Peng WX; Dong XQ; Zhou SF; Yu XQ
    Am J Nephrol; 2008; 28(5):772-83. PubMed ID: 18441523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OAT1 and OAT3 also mediate the drug-drug interaction between piperacillin and tazobactam.
    Wen S; Wang C; Duan Y; Huo X; Meng Q; Liu Z; Yang S; Zhu Y; Sun H; Ma X; Yang S; Liu K
    Int J Pharm; 2018 Feb; 537(1-2):172-182. PubMed ID: 29277663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Species differences of organic anion transporters involved in the renal uptake of 4-amino-3-chlorophenyl hydrogen sulfate, a metabolite of resatorvid, between rats and dogs.
    Takeuchi T; Jinno F; Ebihara T; Moriya Y; Kadotani R; Tagawa Y; Kondo T; Itoh T; Asahi S
    Biopharm Drug Dispos; 2013 May; 34(4):236-46. PubMed ID: 23529922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of Organic Anion Transport in Humans After Treatment With the Drug Probenecid Leads to Major Metabolic Alterations in Plasma and Urine.
    Granados JC; Bhatnagar V; Nigam SK
    Clin Pharmacol Ther; 2022 Sep; 112(3):653-664. PubMed ID: 35490380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal organic anion transporters OAT1 and OAT3 mediate the cellular accumulation of 5-sulfooxymethylfurfural, a reactive, nephrotoxic metabolite of the Maillard product 5-hydroxymethylfurfural.
    Bakhiya N; Monien B; Frank H; Seidel A; Glatt H
    Biochem Pharmacol; 2009 Aug; 78(4):414-9. PubMed ID: 19394312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of JBP485 on renal excretion of acyclovir by the inhibition of OAT1 and OAT3.
    Ye J; Liu Q; Wang C; Meng Q; Peng J; Sun H; Kaku T; Liu K
    Eur J Pharm Sci; 2012 Sep; 47(2):341-6. PubMed ID: 22728397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of renal transporter-mediated drug-drug interactions for a drug which is an OAT substrate and inhibitor using PBPK modelling.
    Ball K; Jamier T; Parmentier Y; Denizot C; Mallier A; Chenel M
    Eur J Pharm Sci; 2017 Aug; 106():122-132. PubMed ID: 28552429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
    Wolman AT; Gionfriddo MR; Heindel GA; Mukhija P; Witkowski S; Bommareddy A; Vanwert AL
    Drug Metab Dispos; 2013 Apr; 41(4):791-800. PubMed ID: 23344796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of hydroxycinnamic acids and their conjugates with organic anion transporters and ATP-binding cassette transporters.
    Wong CC; Barron D; Orfila C; Dionisi F; Krajcsi P; Williamson G
    Mol Nutr Food Res; 2011 Jul; 55(7):979-88. PubMed ID: 21538853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats.
    Zhang Z; Tachikawa M; Uchida Y; Terasaki T
    Mol Pharm; 2018 Mar; 15(3):911-922. PubMed ID: 29436232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.